Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Symbicort (budesonide and formoterol) for the Treatment of Asthma

Drug (Brand / Generic)

Symbicort / budesonide and formoterol

Developer

AstraZeneca

Therapy Class

Anti-asthmatic drug

Product Description

Inhaled corticosteroid (ICS), and long-acting beta2-agonist (LABA)

Current Indication

Asthma

Market Sector

Respiratory

Development Status

Approved in more than 120 countries including the US
Expand

Go Top